Li Jinglin, Zhang Lin, Peng Jiaze, Zhao Chuntao, Li Wenguang, Yu Yang, Huang Xianpeng, Yang Fuyin, Deng Xuan, Yang Xuxu, Zhang Tao, Peng Jiachen
Department of Orthopedics, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Department of Orthopedic Surgery, 920th Hospital of Joint Logistics Support Force, Kunming, China.
Front Cell Dev Biol. 2025 Jun 13;13:1604320. doi: 10.3389/fcell.2025.1604320. eCollection 2025.
Osteomyelitis is a complex infectious bone disease involving pathogen invasion, host immune responses, and dysregulation of the local microenvironment. As a critical component of the innate immune system, macrophages play a pivotal role in inflammatory responses and tissue repair. Their polarization states (M1/M2) directly influence disease progression, while mitochondrial metabolism, as the central hub of cellular energy metabolism, has recently been shown to play a key role in macrophage polarization and functional regulation. However, how mitochondrial metabolism regulates macrophage polarization to affect the pathological mechanisms of osteomyelitis, and how to develop novel therapeutic strategies based on this mechanism, remain critical scientific questions to be addressed. This review systematically summarizes the molecular mechanisms by which mitochondrial metabolism regulates macrophage polarization and its role in osteomyelitis, with a focus on the impact of mitochondrial dynamics (fission/fusion), metabolic reprogramming, and reactive oxygen species (ROS) generation on macrophage polarization. Additionally, potential therapeutic strategies targeting mitochondrial metabolism are analyzed. For the first time, this review integrates the interplay between mitochondrial metabolism and macrophage polarization in osteomyelitis, revealing how mitochondrial dysfunction exacerbates inflammation and bone destruction through metabolic reprogramming. Based on these findings, we propose novel therapeutic strategies targeting mitochondrial metabolism, offering new perspectives and directions for understanding the pathogenesis and clinical treatment of osteomyelitis.
骨髓炎是一种复杂的感染性骨病,涉及病原体入侵、宿主免疫反应和局部微环境失调。作为固有免疫系统的关键组成部分,巨噬细胞在炎症反应和组织修复中起关键作用。它们的极化状态(M1/M2)直接影响疾病进展,而线粒体代谢作为细胞能量代谢的核心枢纽,最近已被证明在巨噬细胞极化和功能调节中起关键作用。然而,线粒体代谢如何调节巨噬细胞极化以影响骨髓炎的病理机制,以及如何基于该机制开发新的治疗策略,仍然是有待解决的关键科学问题。本综述系统总结了线粒体代谢调节巨噬细胞极化的分子机制及其在骨髓炎中的作用,重点关注线粒体动力学(裂变/融合)、代谢重编程和活性氧(ROS)生成对巨噬细胞极化的影响。此外,还分析了针对线粒体代谢的潜在治疗策略。本综述首次整合了骨髓炎中线粒体代谢与巨噬细胞极化之间的相互作用,揭示了线粒体功能障碍如何通过代谢重编程加剧炎症和骨质破坏。基于这些发现,我们提出了针对线粒体代谢的新治疗策略,为理解骨髓炎的发病机制和临床治疗提供了新的视角和方向。
Arch Ital Urol Androl. 2025-6-30
Immun Inflamm Dis. 2025-6
JBI Database System Rev Implement Rep. 2016-4
Cochrane Database Syst Rev. 2022-5-20
Cochrane Database Syst Rev. 2018-2-6
Cell Commun Signal. 2023-11-2
Virulence. 2025-12
J Colloid Interface Sci. 2025-4-15